Early experience with the Senhance®-laparoscopic/robotic platform in the US

The introduction of new robotic platforms will grow considerably in the near future as several manufacturers are in the developing stages of different innovative systems. One of the newest systems, the Senhance (R) platform (TransEnterix Surgical Inc., Morrisville, NC, USA) has been utilized in a variety of cases in Europe but only recently approved for limited clinical use in the United States. Here, we present our initial experience with this state-of-the-art system in patients requiring a variety of procedures.